Literature DB >> 9347833

Esophageal replacement for end-stage benign esophageal disease.

T J Watson1, J H Peters, T R DeMeester.   

Abstract

The fact that esophageal resection and foregut reconstruction for benign disease can be performed with only a 2% mortality and minimal morbidity is encouraging news to patients who are crippled by the various manifestations of end-stage disease. The continuation of slow, anxious, and socially restricted alimentation or the maintenance of nutrition by enteral or parenteral means is unnecessary. The patient should be referred to a unit skilled in evaluating foregut function, performing esophageal replacement surgery, and caring for patients in the perioperative period. In our experience, the colon, when available, is the preferred conduit for esophageal replacement over the long term. Even though some subtle preoperative symptoms of foregut dysfunction may persist after surgery, the overall outcome is generally judged to be satisfactory. Indeed, patients can re-enter society and live a normal and fulfilled life after remedial surgery. Prolonged attempts at medical management of patients with severe derangements of esophageal structure and function are not warranted. Long-term esophageal replacement for severe end-stage benign disease can be accomplished with low mortality, a high degree of success, and a marked improvement in the quality of alimentation. Reconstruction restores the pleasure of eating and is viewed by the patient to be highly successful.

Entities:  

Mesh:

Year:  1997        PMID: 9347833     DOI: 10.1016/s0039-6109(05)70607-1

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Surgical treatment of giant esophageal leiomyoma.

Authors:  Bang-Chang Cheng; Sheng Chang; Zhi-Fu Mao; Mao-Jin Li; Jie Huang; Zhi-Wei Wang; Tu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

2.  Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses.

Authors:  Kevin M Reavis; Eugene Y Chang; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

3.  Transhiatal esophageal resection for corrosive injury.

Authors:  Narendar Mohan Gupta; Rajesh Gupta
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

4.  Gastric tube interposition for corrosive esophagitis associated with pyloric stenosis.

Authors:  Atsushi Matsuki; Tatsuo Kanda; Shin-ichi Kosugi; Tsutomu Suzuki; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

5.  Advanced adenocarcinoma in a colonic interposition segment.

Authors:  Madan Raj Aryal; Naba Raj Mainali; Leena Jalota; John F Altomare
Journal:  BMJ Case Rep       Date:  2013-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.